J 2023

Post-COVID Syndrome and Cardiorespiratory Fitness-26-Month Experience of Single Center

SOVA, Milan, Eliska SOVOVA, Jaromir OZANA, Katarina MORAVCOVA, Marketa SOVOVA et. al.

Basic information

Original name

Post-COVID Syndrome and Cardiorespiratory Fitness-26-Month Experience of Single Center

Authors

SOVA, Milan (203 Czech Republic, belonging to the institution), Eliska SOVOVA (203 Czech Republic), Jaromir OZANA (203 Czech Republic), Katarina MORAVCOVA (203 Czech Republic), Marketa SOVOVA (203 Czech Republic), Libor JELINEK (203 Czech Republic), Jan MIZERA (203 Czech Republic) and Samuel GENZOR (203 Czech Republic, guarantor)

Edition

LIFE-BASEL, BASEL, MDPI, 2023, 2075-1729

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30203 Respiratory systems

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.200 in 2022

RIV identification code

RIV/00216224:14110/23:00130752

Organization unit

Faculty of Medicine

UT WoS

000958163800001

Keywords in English

post-COVID syndrome; cardiopulmonary exercise testing

Tags

Tags

International impact, Reviewed
Změněno: 10/5/2023 14:23, Mgr. Tereza Miškechová

Abstract

V originále

Introduction: Persistent post-COVID syndrome, also referred to as long COVID, is a pathologic entity that involves persistent physical, medical, and cognitive sequelae following COVID-19. Decreased fitness has repeatedly been reported in numerous studies dealing with post-COVID syndrome, however, it is still not fully clear which groups of patients may be more susceptible for persisting symptoms. Aim: The aim of our study was to evaluate the number of post-COVID patients with cardiac symptoms, where these patients were evaluated by CPET and the results compared with a control group of patients. Methods: Follow-up of patients in post-COVID outpatient clinic from 1 March 2020 to 31 May 2022. Inclusion criteria were positive PCR test for SARS-CoV-2 and age 18-100. The initial examination was performed 4-12 weeks after the disease onset. All patients with possible cardiac symptoms had completed cardiopulmonary exercise testing. The control group was randomly selected from a database of clients in 2019, with the preventive reason for evaluation. Results: From 1 March 2020 to 31 May 2022, 2732 patients (45.7% males) were evaluated with a mean age of 54.6 +/- 14.7. CPET was indicated only in 97 patients (3.5%). Seventy-four patients (26 male) achieved the exercise maximum and a comparison were made with a control group (same age (p = 0.801), BMI (p = 0.721), and sex ratio). No significant dependence between the parameter VO2 max mL/kg/min and post-COVID disability was demonstrated (p = 0.412). Spearman's correlation analysis did not show a significant relationship between the parameter VO2 max mL/kg/min and the severity of COVID-19 (p = 0.285). Conclusions: Cardiac symptoms occurred in only a small percentage of patients in our study. There is a need for further studies that would objectively evaluate the effect of COVID-19 disease on the patient's health.